Table 1. Summary of treatment success by antibiotic type in CD: RCT and select uncontrolled trials.

Antibiotic	Positive trial	Negative trial	Ambiguous result
Metronidazole	4 (90,92,96,105)	2 (75,79)	1 (82)
Ciprofloxacin	3 (83,92,96)	2 (75,79)	0
Rifaximin	2 (78,94)	0	1 (76)
Clarithromycin	2 (80,95)	0	1 (81)
Anti-MAP Rx	5 (77,91,93,97,98)	3 (84,85,106)	1 (68)

MAP, Mycobacterium avium subspecies paratuberculosis; CD, Crohn’s disease; RCT, randomized controlled trial.